A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
EUROAPI SA operates in the Medical - Devices industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 985M | 985M | 1.1B | - |
| Net Income | -141M | -141M | -206M | -16M |
| EPS | $-1.49 | $-1.49 | $-2.19 | $-0.17 |
| Free Cash Flow | 133M | 133M | 5.5M | 47M |
| ROIC | -10.4% | -8.4% | -15.7% | -0.0% |
| Gross Margin | 15.6% | 15.6% | 16.2% | - |
| Debt/Equity | 0.00 | 0.18 | 0.19 | 0.15 |
| Dividends/Share | $0.00 | - | - | - |
| Operating Income | -130M | -130M | -254M | -842K |
| Operating Margin | -13.2% | -13.2% | -23.1% | - |
| ROE | -13.3% | -13.6% | -18.9% | -1.4% |
| Shares Outstanding | 95M | 95M | 94M | 94M |
| Metric | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | N/A | 1.1B | 985M | 985M |
| Gross Margin | N/A | 16.2% | 15.6% | 15.6% |
| R&D | -23M | -32M | -28M | -28M |
| SG&A | N/A | 459M | 304M | 304M |
| EBIT | -842K | -254M | -130M | -130M |
| Op. Margin | N/A | -23.1% | -13.2% | -13.2% |
| Net Income | -16M | -206M | -141M | -141M |
| Net Margin | N/A | -18.7% | -14.3% | -14.3% |
| Non-Recurring | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||
| ROIC | -0.0% | -15.7% | -8.4% | -10.4% |
| ROE | -1.4% | -18.9% | -13.6% | -13.3% |
| ROA | -0.9% | -11.5% | -8.4% | -8.8% |
| Cash Flow | ||||
| Op. Cash Flow | 47M | 5.5M | 133M | 133M |
| Free Cash Flow | 47M | 5.5M | 133M | 133M |
| Owner Earnings | 47M | -323M | 50M | 50M |
| CapEx | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 329M | 83M | 83M |
| Growth CapEx | N/A | N/A | N/A | 0 |
| D&A | 0 | 329M | 83M | 83M |
| CapEx/OCF | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||
| Dividends Paid | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A |
| Share Buybacks | 1.4M | 651K | 108K | 108K |
| Buyback Yield | 0.1% | 0.1% | 0.0% | 0.1% |
| Stock-Based Comp | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||
| Net Debt | 100M | 153M | 113M | -79M |
| Cash & Equiv. | 78M | 37M | 79M | 79M |
| Long-Term Debt | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.15 | 0.19 | 0.18 | 0.00 |
| Interest Coverage | -0.2 | -21.5 | -4.3 | -4.3 |
| Equity | 1.2B | 1.0B | 1.1B | 1.1B |
| Total Assets | 1.8B | 1.8B | 1.6B | 1.6B |
| Total Liabilities | 659M | 743M | 547M | 547M |
| Intangibles | N/A | 37M | 41M | 41M |
| Retained Earnings | N/A | N/A | N/A | N/A |
| Working Capital | 597M | 511M | 542M | 542M |
| Current Assets | 1.1B | 1.1B | 897M | 897M |
| Current Liabilities | 481M | 553M | 355M | 355M |
| Per Share Data | ||||
| EPS | -0.17 | -2.19 | -1.49 | -1.49 |
| Owner EPS | 0.50 | -3.44 | 0.53 | 0.53 |
| Book Value | 12.47 | 10.73 | 11.23 | 11.23 |
| Cash Flow/Share | 0.50 | 0.06 | 1.40 | -0.61 |
| Dividends/Share | N/A | N/A | N/A | 0.00 |
| Shares Out. | 93.8M | 93.9M | 94.6M | 94.6M |
| Valuation | ||||
| P/E Ratio | -88.7 | -2.9 | -2.0 | -0.9 |
| P/FCF | 29.7 | 107.4 | 2.1 | 0.9 |
| EV/EBIT | N/A | N/A | N/A | N/A |
| Price/Book | 1.2 | 0.6 | 0.3 | 0.1 |
| Price/Sales | N/A | 0.5 | 0.3 | 0.1 |
| FCF Yield | 3.4% | 0.9% | 48.0% | 108.8% |
| Market Cap | 1.4B | 595M | 277M | 122M |
| Avg. Price | 16.36 | 11.30 | 4.12 | 1.29 |
| Year-End Price | 14.95 | 6.34 | 2.92 | 1.29 |
EUROAPI SA passes 2 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 0.9x vs a median of 15.9x. The company's 5-year average gross margin is 15.9%. At current prices, the estimated annualized return to fair value is +7.7%.
EUROAPI SA (EAPI-PA) has a 5-year average return on invested capital (ROIC) of -8.0%. This is below average and may indicate limited pricing power.
EUROAPI SA (EAPI-PA) has a market capitalization of $122M. It is classified as a small-cap stock.
EUROAPI SA (EAPI-PA) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.09%.
EUROAPI SA (EAPI-PA) operates in the Medical - Devices industry, within the Healthcare sector.
EUROAPI SA (EAPI-PA) reported annual revenue of $985 million in its most recent fiscal year, based on SEC EDGAR filings.
EUROAPI SA (EAPI-PA) has a net profit margin of -14.3%. The company is currently unprofitable.
EUROAPI SA (EAPI-PA) generated $133 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
EUROAPI SA (EAPI-PA) has a debt-to-equity ratio of 0.18. This indicates a conservatively financed balance sheet.
EUROAPI SA (EAPI-PA) reported earnings per share (EPS) of $-1.49 in its most recent fiscal year.
EUROAPI SA (EAPI-PA) has a return on equity (ROE) of -13.6%. A negative ROE may indicate losses or negative equity.
EUROAPI SA (EAPI-PA) has a 5-year average gross margin of 15.9%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 3 years of financial data for EUROAPI SA (EAPI-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
EUROAPI SA (EAPI-PA) has a book value per share of $11.23, based on its most recent annual SEC filing.
No recent press releases.